Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

A new lead in treating chronic social defeat stress

Published on: 24/05/2017 Reading time: 1 min
Une personne en dépression

24Chronic social defeat stress is a cause in many cases of depression. In humans, chronic social stress is built over time based on our past social interaction, with numerous consequences on both a psychological and neurological level.

Beyond depression, many patients display cognitive disorders including memory and attention loss, and complicated decision-making. Current therapy is focused on treating depression, yet its impact on cognitive deficiency remains unclear.

Institut du Cerveau - ICM researchers focused on the behavioral and molecular impact of chronic social defeat stress in an experimental model summarizing similar symptoms to those observed in humans. They also studied the effect of a molecule named agomelatine that has demonstrated antidepressant and anxiolytic effects.

In addition to behavioral modifications and memory disorders observed in animals, researchers highlighted a decrease in the expression of certain genes of the hippocampus, an area of the brain that plays a crucial role in memory and known to be directly affected in social stress. Results showed that agomelatine has an effect on cognitive disorders and gene expression in the hippocampus.

This data suggests that agomelatine may be of particular interest in treating cognitive disorders associated with depression. Complementary studies will focus on studying the molecule’s mechanisms.

Sources

Effect of agomelatine on memory deficits and hippocampal gene expression induced by chronic social defeat stress in mice.
https://www.nature.com/articles/srep45907
Martin V, Allaïli N, Euvrard M, Marday T, Riffaud A, Franc B, Mocaër E, Gabriel C, Fossati P, Lehericy S, Lanfumey L. Sci Rep. 2017 Apr 4;8:45907

Our news on the subject

Le développement du cerveau a une part d’aléatoire
The stochastic aspect of brain development
Although every person’s personality is the result of genetic and environmental factors, these are not the only factors at play. Bassem Hassan and his team at Paris Brain Institute have discovered that, in fruit flies (drosophila), individuality also...
05.12.2025 Research, science & health
Analyse MERSCOPE
New treatment pathways for brain malformation-linked focal epilepsy?
A study by Stéphanie Baulac’s team has revealed somatic mutations in different cell types in patients with type 2 focal cortical dysplasia. This disease causes drug-resistant epileptic seizures, for which the main treatment option is currently...
05.12.2025 Research, science & health
Un iceberg
The ICEBERG cohort, 10 years of collective scientific and medical mobilization
The ICEBERG cohort, initiated 10 years ago, is interested in studying factors predictive of the onset and progression of Parkinson’s disease.
05.15.2025 Research, science & health
La huntingtine est une protéine indispensable au développement embryonnaire, à la formation et au maintien du tissu cérébral.
Huntington's Disease: The Energy Hypothesis Gets Traction
Huntington's disease, a rare hereditary neurological disorder, is associated with an energy deficit that precedes the onset of symptoms and is closely linked to their progression. At Paris Brain Institute, Fanny Mochel and her colleagues are testing...
02.11.2025 Research, science & health
À la recherche de marqueurs d’imagerie dans la démence frontotemporale
Searching for Imaging Markers in Frontotemporal Dementia
Could exploring the relationships between different brain networks help us understand frontotemporal dementia (FTD)? This neurodegenerative disease, which progresses at varying rates, is often diagnosed late—when clinical signs are already severe. At...
01.07.2025 Research, science & health
Monocyte – un globule blanc qui se différencie en macrophage. Crédit : Université d’Edinbourg.
Discovery of a Macrophage Anomaly in Multiple Sclerosis
Certain patients with multiple sclerosis (MS) can partially regenerate myelin—the protective sheath that surrounds nerve fibers—which is damaged during the evolution of the disease. In studying how immune cells influence this remyelination...
12.19.2024 Research, science & health
See all our news